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Association of fatness with chronic metabolic diseases is a well-established fact, and a high prevalence of risk factors for these
disorders has increasingly been reported in the third world. In order to incorporate any preventive strategies for such risk factors
into clinical practice, decision-makers require objective evidence about the associated burden of disease. A cross-sectional study of
1321 adults from one of the districts of Balochistan, among the most economically challenged areas of Pakistan, was carried out for
the measures of fatness and self-reported comorbidities. Bodymass index (BMI), waist circumference (WC), and waist-to-hip ratio
(WHR)weremeasured and demographic information and self-reported comorbidities were documented.The prevalence of obesity
was 4.8% (95% CI: [3.8, 6.1]) and 21.7% (95% CI: [19.5, 24.0]), as defined by the World Health Organization (WHO) international
and Asia/Asia-Pacific BMI cut-offs, respectively. The proportion exhibiting comorbidity increased with increasing levels of fatness
in a dose-response relationship (𝑝 value < .001). An interaction of weight status with gender was observed to produce a significantly
(𝑝 = .033) higher comorbidity among overweight women (odds ratio (OR) = 6.1 [1.2, 31.7]) compared with overweight men (OR =
1.1 [0.48, 2.75], 𝑝 = .762).
1. Introduction
Globally, the prevalence of obesity more than doubled
between 1980 and 2014. Around 1.9 billion (39%) adults, 38%
of men and 40% of women, have been reported to have
weights above the normal range. Of these, over 600 million
(13%) were found to be obese (11% ofmen and 15% of women)
[1]. This obesity epidemic, previously thought to be a burden
of affluent societies, has been noticed to have reached the low-
andmiddle-income countries as a result of the epidemiologic
transition [2–4].
Developing countries have been noted to be facing a dual
burden of undernutrition and overnutrition simultaneously,
exerting substantial strains on the already overburdened
health systems [4]. The prevalence of overweight and obesity
has increased severalfold in Asia, especially in South Asia
[5], over the past few decades, with the extent varying
between countries [6], although not very different from that
in the United States [7]. Pakistan stands eighth among the 10
countries hosting half of the 693 million obese individuals in
the world: USA, China, India, Russia, Brazil, Mexico, Egypt,
Pakistan, Indonesia, and Germany [8].
Obesity is a major risk factor for a range of chronic
disorders such as cardiovascular diseases (CVD), hyperten-
sion, type 2 diabetes mellitus (DM), hypercholesterolemia,
osteoarthritis (OA),major depression [9], and certain cancers
(CA) [8]. Globally, 23% of CVD, 44% of type 2 DM, and
7–41% of certain cancers are attributable to overweight and
obesity, with a major share from developing countries [5].
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Obesity has been found to be associated with at least as
muchmorbidity as poverty, smoking, and alcoholism, despite
receiving lesser attention in clinical practice and public health
domains [10]. In Asia, there is a general paucity of research
on obesity using metrics other than BMI, and even for
BMI, the cut-off values used are not Asia-Pacific-specific as
recommended by the WHO.
The plight of multiple comorbid states has been reported
to afflict up to 50% of adult populations [11], with the
estimates varying from 13% to 95% [12]. A palpable lack of
research focus regarding the overall burden of this important
health problem as well as the balance of inquiry regarding
geographic and diagnostic entities has been highlighted,
especially for the relatively less disadvantaged tiers of pop-
ulations in the Eastern Mediterranean region [13].
The aim of this study was to determine the prevalence of
obesity and its association with self-reported comorbidity by
using different anthropometric measures: BMI (both WHO
international and Asian cut-offs), waist circumference (WC),
and waist-to-hip ratio (WHR). We also investigated whether
the associations varied by gender among a representative
sample of adults from the population of the Lasbela District,
Balochistan.
2. Methods
2.1. Sample Size. Assuming a 15% prevalence of obesity in
Pakistan [14], a sample size of 1225 individuals would estimate
the true population proportion of obese persons with a
2% margin of error at 95% confidence level. Adding a 10%
nonresponse rate, a sample size of 1347 was targeted.
2.2. Data Source. Data were collected using multistage strati-
fied random sampling [15]. Out of a sampling frame of 30,000
households from 22 union councils treated as strata, a simple
random sample of 270 households and 1321 individuals was
selected after exclusion of nonresponders, with a number
proportionate to the population from each union council. A
list of households in each union council was obtained from
the local census offices.
2.3. Data Collection. Data for all persons 18 years of age
or older, excluding pregnant females, were collected. Face-
to-face interviews were conducted by staff specially trained
in the measurement process and filling the data collection
instrument. The information gathered consisted of demo-
graphics (age, gender, education, monthly income, occupa-
tion, marital status, and smoking status) and self-reported
physician-diagnosed comorbidity (type 2 DM, CVD, hyper-
tension, hypercholesterolemia, OA, and CA). Anthropomet-
ric measurements including height, weight, WC, and hip
circumference (HC)were taken,with standard operating pro-
cedures. Each measurement was taken three times in tandem
and then the mean was calculated. BMI was calculated by
dividing weight in kilograms (measured after removal of
shoes and heavy outer clothing using a CAMRY weighing
scale) by the square of height in meters (measured without
shoes using a nonstretchable tape). WHR was calculated by
dividing WC (measured by a nonstretchable tape at the level
of the umbilicus) by hip circumference (measured at the
widest point using the same tape) [9].
2.4. Operational Definitions
2.4.1. Comorbidity. Within the context of this study, comor-
bidity is defined as a self-report of a doctor’s diagnosis or
taking medication prescribed by a doctor for one or more
of the following conditions: CVD (coronary heart disease
or stroke), hypertension, hypercholesterolemia, type 2 DM,
osteoarthritis, or cancer [9].
2.4.2. Obesity
Body mass index (BMI) based international cut-offs:
underweight (<18.5 kg/m2), normal weight (18.5–
24.9 kg/m2), overweight (25.0–29.9 kg/m2), and obese
(≥30 kg/m2).
The World Health Organization (WHO) recom-
mended cut-offs for Asia and Asia-Pacific region:
underweight (<18.5 kg/m2), normal weight (18.5–
22.9 kg/m2), overweight (23.0–24.9 kg/m2), and
obese (≥25 kg/m2) [16].
Waist circumference (WC) based cut-offs: normal
weight (<94 cm), overweight (94–101.99 cm), and
obese (≥102 cm) for men; normal weight (<80 cm),
overweight (80–87.99 cm), and obese (≥88 cm) for
women.
Waist-to-hip ratio (WHR) based cut-offs: normal
weight (<0.90), overweight (0.90–0.99), and obese
(≥1) for men; normal weight (<0.80), overweight
(0.80–0.84), and obese (≥0.85) for women [17].
2.5. Ethical Considerations. This study was conducted after
approval from the Ethical Board of the Khyber Medical
University, Peshawar (KMU-EB). Consent was taken from
the participants on a consent form written in English and
Urdu and after explaining to them the elements of the
informed consent, their autonomy, confidentiality, right to
withdraw at any time they felt uncomfortable, measurement
process, and the whole purpose of the study.
3. Statistical Analysis
Chi-square (𝜒2) tests are used for cross-tabulation analyses.
Associations among dichotomized anthropometric measures
and comorbidity are assessed by means of univariate and
multivariate logistic regression models. Odds ratios (OR)
with 95% confidence intervals (CI) are reported and receiver
operating characteristic curves presented for these analyses.
In the multivariate model, possible confounding factors, that
is, gender, age, marital status, education, monthly income,
occupation/work status, and smoking status, are adjusted for.
Significance of interactions in logistic regression is assessed
using Wald’s test. Stata version 12.1 (StataCorp, College
Station, Texas) has been used to carry out analyses. All tests
of statistical significance are two-tailed with an alpha of .05.
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Figure 1: Means of anthropometric measurements (overall) with having self-reported comorbidity.
Cohen’s 𝑑 and 𝑟-squared are reported as measures of
effect size for 𝑡-tests, Crame´r’s 𝑉 for chi-square tests, 𝑟 for
two-sample tests of proportions, and OR with CI and area
under the receiver operating characteristic curve for logistic
regression analyses.
4. Results
Complete data were available for 1321 persons. With 26
nonresponders, the response rate was 98%. Compared with
the participating family members, the nonresponders did not
differ in any significant way.
Of the 1321 participants, 659 (49.89%) were males. Mean
(M) age of the participants was 32.21 years, with a standard
deviation (SD) of 12.83 years.
Mean BMI, WC, and WHR were 22.22 kg/m2 (SD:
4.14 kg/m2), 79.61 cm (SD: 10.86 cm), and 0.87 (SD: 0.04),
respectively.
Mean BMI,WC, andWHRwere all significantly different
between those who had one or more comorbid conditions
and those without any comorbidity (𝑡(1319) = −10.3915,
−9.7439, and −5.0954; all 𝑝 values < .001; 𝑑 = 0.72, 0.99, and
0.52; 𝑟2 = 0.08, 0.07, and 0.02, resp.) (Figure 1).
Among men, mean BMI, WC, and WHR were all sig-
nificantly different between those who had one or more
comorbid conditions and those without any comorbidity
(𝑡(1319) = −4.5358, −7.9175, and −4.3972; all 𝑝 values < .001;
𝑑 = 0.69, 1.2, and 0.67; 𝑟2 = 0.03, 0.09, and 0.03, resp.)
(Figure 2).
Among women, mean BMI, WC, and WHR were all
significantly different between those who had one or more
comorbid conditions and those without any comorbidity
(𝑡(1319) = −9.7182, −6.1836, and −2.9383; 𝑝 values < .001,
<.001, and .003; 𝑑 = 1.3, 0.083, and 0.4; 𝑟2 = 0.12, 0.06, and
0.01, resp.) (Figure 3).
While WC differed significantly between men (M =
80.4 cm, SD = 11.4 cm) and women (M = 78.8 cm, SD =
10.3 cm) (𝑡(1319) = 2.5360, 𝑝 = .011, 𝑑 = .14, 𝑟2 = .005),
BMI and WHR did not show such difference (𝑝 values: .667
and .901, resp.).
The prevalence of obesity was 4.84% (95% CI: [3.8, 6.1])
by international cut-offs and 21.73% [19.5, 24.0] on Asian
cut-offs of BMI. On WC measurement and WHR measure-
ment, 10.9% [9.3, 12.7] and 44.4% [41.7, 47.2] were obese,
respectively. An obese individual was more likely to be ≥45
years of age (two-sample test of proportions: 𝑧 = −6.2641,𝑝 <
.001, 𝑟 = −0.08), married (𝑧 = −3.5053, 𝑝 < .001, 𝑟 = −0.1),
uneducated (𝑧 = 2.6437, 𝑝 = .008, 𝑟 = 0.07), and a smoker
(𝑧 = −2.9285, 𝑝 = .003, 𝑟 = −0.08). A person with one
or more comorbidities, compared to those without one, was
more likely to be female (𝑧 = −4.7976, 𝑝 < .001, 𝑟 = −.13),
forty-five years of age or older (𝑧 = −15.1801, 𝑝 < .001, 𝑟 =
−.42), obese (𝑧 = −8.3415, 𝑝 < .001, 𝑟 = −.23), uneducated
(𝑧 = 6.1805, 𝑝 < .001, 𝑟 = −.17), and current or ex-smoker
(𝑧 = −3.0239, 𝑝 = .0025, 𝑟 = −.08).
Overall, 8.02% [6.6–9.6%] of the participants reported
themselves as having one or more comorbidities, among
whom 43.4% [33.8, 53.4] were men and 56.6% [46.6, 66.2]
were women.The difference in proportion of the two genders
among those who reported comorbidity was statistically not
significant (two-sample test of proportions: 𝑧 = −1.9219,
𝑝 = .06, 𝑟 = −0.13).
The prevalence of various comorbid states, with
95% confidence intervals, was as follows: cardiovascular
disease, 1.7% [1.0, 2.5]; hypertension, 5.3% [4.2, 6.6]; type
2 diabetes mellitus, 2.2% [1.5, 3.1]; hypercholesterolemia,
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Figure 2: Means of anthropometric measurements (men) with having self-reported comorbidity.
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Figure 3: Means of anthropometric measurements (women) with having self-reported comorbidity.
0.9% [0.5, 1.6]; and osteoarthritis, 4.2% [3.2, 5.4]. None of
the participants reported any malignancy.
All of the following variables were significantly associated
with self-reported comorbidity: obesity, using both interna-
tional and Asian cut-offs for BMI (𝜒2 (3, 𝑁: 1321) = 99.16
and 72.26, both 𝑝 values < .001, 𝑉 = 0.27 and .23, resp.),
obesity as defined by WC (𝜒2 (2,𝑁: 1321) = 113.70, 𝑝 < .001,
𝑉 = 0.29), obesity as defined by WHR (𝜒2 (2, 𝑁: 1321) =
21.32, 𝑝 < .001, 𝑉 = 0.13), age (𝜒2 (3, 𝑁: 1321) = 255.18,
𝑝 < .001, 𝑉 = 0.44), marital status (𝜒2 (1, 𝑁: 1321) = 21.48,
𝑝 < .001, 𝑉 = 0.13), educational status (𝜒2 (1, 𝑁: 1321) =
38.22, 𝑝 < .001, 𝑉 = −0.17), and smoking status (𝜒2 (2, 𝑁:
1321) = 9.42, 𝑝 = .009, 𝑉 = 0.08) (Table 1).
In overall multiple logistic regression analysis, after
adjusting for potential confounders, that is, gender, age,
marital status, education, monthly income, occupation/work
BioMed Research International 5
Table 1: Characteristics of the participants by self-reported comorbidity.
Self-reported comorbidity
𝑝 valueNo Yes
𝑁 = 1215 (91.98%) 𝑁 = 106 (8.02%)
𝑁 (%) 𝑁 (%)
Gender
Men 613 (93.02) 46 (6.98) 0.163
Women 602 (90.94) 60 (9.06)
Age (years)
18–30 758 (98.06) 15 (1.94) <0.001
31–44 299 (95.22) 15 (4.78)
45–59 112 (73.68) 40 (26.32)
≥60 46 (56.10) 36 (43.90)
BMI category (international cut-offs)
Underweight 226 (96.58) 8 (3.42) <0.001
Normal weight 759 (94.88) 41 (5.12)
Overweight 189 (84.75) 34 (15.25)
Obesity 41 (64.06) 23 (35.94)
BMI category (Asian cut-offs)
Underweight 226 (96.58) 8 (3.42) <0.001
Normal weight 572 (95.65) 26 (4.35)
Overweight 187 (92.57) 15 (7.43)
Obesity 230 (80.14) 57 (19.86)
WC category
Normal weight 903 (95.35) 44 (4.65) <0.001
Overweight 212 (92.17) 18 (7.83)
Obesity 100 (69.44) 44 (30.56)
WHR category
Normal weight 587 (95.14) 30 (4.86) <0.001
Overweight 98 (83.76) 19 (16.24)
Obesity 530 (90.29) 57 (9.71)
Marital status
Unmarried 483 (96.41) 18 (3.59) <0.001
Married 732 (89.27) 88 (10.73)
Education
Uneducated 571 (87.31) 83 (12.69) <0.001
Educated (≥5 years) 644 (96.55) 23 (3.45)
Monthly income (PKR)
Low income (≤8500) 280 (92.11) 24 (7.89) 0.925
Middle income (8501–103900) 935 (91.94) 82 (8.06)
Occupation/work status
Unemployed 752 (91.93) 66 (8.07) 0.990
Employed (skilled) 236 (92.19) 20 (7.81)
Labor (unskilled) 227 (91.90) 20 (8.10)
Smoking status
Never smoked 938 (93.24) 68 (6.76) 0.009
Ex-smoker 85 (86.73) 13 (13.27)
Current smoker 192 (88.48) 25 (11.52)
Comorbidity is the presence of one or more of the following conditions: type 2 DM, hypertension, CVD, hypercholesterolemia, OA, and CA. The reported 𝑝
values are for chi-square tests of independence for categorical data.
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Figure 4: Areas under the ROC curve from logistic regression for
males and females.
status, and smoking status, the association between obesity
(as defined by international and Asia-specific cut-off values
of BMI) and comorbidity was significant (odds ratios (OR)
= 5.75 [2.84, 11.64] and 2.87 [1.66, 4.97], resp., both 𝑝 values
< .001). Overweight was significantly associated with comor-
bidity only as defined by international cut-offs only (OR =
1.89 [1.10, 3.26], 𝑝 = 0.021).
Association between obesity as defined by waist cir-
cumference and comorbidity was significant (OR = 3.76
[2.06, 6.85], 𝑝 < .001). However, obesity as defined by
waist-to-hip ratio did not show a significant association with
comorbidity (OR = 1.72 [.63, 4.72], 𝑝 = .292) (Table 2).
In gender-specific multiple logistic regression analysis,
the association between obesity and comorbidity for men
was significant for international BMI cut-offs (OR = 8.49
[2.50, 28.81], 𝑝 = .001) but not for Asian cut-offs (OR =
1.96 [.86, 4.48], 𝑝 = .109); for women, the association was
significant for both cut-offs (OR= 5.19 [2.03, 13.26],𝑝 = .001;
OR = 3.73 [1.68, 8.29], 𝑝 = .001, resp.) (Figure 4).
The international cut-offs defined overweight was sig-
nificantly associated with the outcome of comorbidity for
women only (OR= 2.64 [1.23, 5.67],𝑝 = .013), an association
not observed in men or with the Asian cut-offs of BMI for
women.
Obesity as defined by waist circumference was signifi-
cantly associated with comorbidity for men as well as women
(OR = 6.38 [2.24, 18.19], 𝑝 = 0.001; OR = 3.38 [1.49, 7.64],
𝑝 = .004, resp.). As defined by waist-to-hip ratio, obesity did
not show significant association for either sex.
The overweight category by both cut-offs for BMI showed
an interaction with gender to produce significant association
(OR: 6.05 [1.16, 31.74],𝑝 = .033) with the outcome of comor-
bidity for women but not men (OR = 1.14456 [0.48, 2.75],
𝑝 = .762).
There was a significant linear trend of increasing comor-
bidities with progressively increasing weight categories, both
by international and by Asia/Asia-Pacific cut-offs (Cuzick’s
tests for linear trend: z = 8.83 and 7.73, resp., p values < .001).
5. Discussion
Worldwide, obesity has been reported to incur a twofold
increase in the risk of diabetes, hypertension, heart failure,
ischemic stroke, ischemic heart disease, and osteoarthritis
[18–22]. Our study has found a significant dose-response
relationship between increasing comorbidities and increasing
weight.
The association has important implications for public
health planning and management as health effects of obesity
at individual and community levels manifest themselves
through these comorbid states, which we have shown to be
increasing in direct proportion with increasing weight.
Thirty-seven percent [34.4, 39.7] of the participants
in this study were either overweight (15.3% [13.4, 17.3])
or obese (21.7% [19.5, 24.0]), according to the recom-
mended BMI cut-offs for Asian populations. Twenty percent
[15.40, 24.95] of the obese individuals had one or more
comorbid conditions.
Our results show a significantly higher prevalence of
obesity among those who were 45 years of age or older,
married, uneducated, and smokers. Such associations have
been reported by various studies across the world including
Asia and South Asia [23].
We have found the prevalence of obesity to be
21.7% [19.5, 24.0] and that of underweight to be
17.8% [15.7, 19.9], highlighting the simultaneous burden of
the two extremes [4]. The prevalence of underweight that
we found is higher than that reported in Pakistan previously
(12.3%) [14], probably a reflection of the locale specific
economic realities.
Our finding of a significant association of obesity with
comorbidities has been reported previously [24] but the
levels of different anthropometricmeasurements at which the
participants reported comorbidity in our study were lesser
compared to those reported in USA and Europe, probably
because Asians are known to carry greater body fat content
for a given BMI [25].
This study has shown that the association between
BMI (international cut-offs) and self-reported comorbidity
differs by the gender; while only obese, not overweight,
men were significantly more likely to report comorbidity,
both overweight and obese women showed such association.
Overweight men, compared with overweight women, have
been found to report relatively better quality of life, better
psychological health, and more happiness [26–28].
5.1. Strengths and Limitations of the Study. The sampling
technique for this study was robust enough to ensure rep-
resentativeness of the sample and external validity. Different
anthropometric measures of obesity as well as various cut-off
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values were used to provide a broader range of assessment
for measures of fatness. Anthropometric measurements were
done by trained staff rather than relying on self-reported
obesity.
Other than being subject to various biases known to beset
cross-sectional studies, causality cannot be inferred from the
reported associations from this study.
6. Conclusion
Comorbidities increase with increasing weight in a dose-
response relationship.With the changing social structure and
lifestyles in the area, the problem can only get worsewith time
if not addressed by healthcare planners.
7. Recommendations
In order to reduce the healthcare costs, effective preventive
strategies have to be put in place at various tiers of healthcare
delivery systems.
Additional research with longitudinal design is needed
to define the temporal characteristics of association between
obesity and its associated comorbidities.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
References
[1] WorldHealthOrganization, “Controlling the global obesity epi-
demic: the challenge,” Nutrition, WHO, 2008, http://www.who
.int/nutrition/topics/obesity/en/.
[2] A. Boutayeb and S. Boutayeb, “The burden of non communica-
ble diseases in developing countries,” International Journal for
Equity in Health, vol. 4, 2005.
[3] G. A. Stevens, G. M. Singh, and Y. Lu, “National, regional,
and global trends in adult overweight and obesity prevalences,”
Population Health Metrics, vol. 10, article 22, 2012.
[4] R. F. Florentino, “The burden of obesity in Asia: Challenges in
assessment, prevention and management,” Asia Pacific Journal
of Clinical Nutrition, vol. 11, no. s8, pp. S676–S680, 2002.
[5] “Don’t get the idea that all Asian populations are the same,”
in Proceedings of the World Congress of Europian Society of
Cardiology, B. JP, Ed., Barcelona , Spain2006, 2006.
[6] A. M. Prentice, “The emerging epidemic of obesity in develop-
ing countries,” International Journal of Epidemiology, vol. 35, no.
1, pp. 93–99, 2006.
[7] K.H. Yoon, J. H. Lee, J.W.Kim et al., “Epidemic obesity and type
2 diabetes in Asia,”The Lancet, vol. 368, no. 9548, pp. 1681–1688,
2006.
[8] M. Ng, T. Fleming, M. Robinson, and et al, “Global, regional,
and national prevalence of overweight and obesity in children
and adults during 1980–2013: a systematic analysis for the
Global Burden of Disease Study 2013,”The Lancet, vol. 384, no.
9945, pp. 766–781, 2014.
[9] Z. Ul-Haq, D. J. Smith, B. I. Nicholl et al., “Gender differ-
ences in the association between adiposity and probable major
depression: A cross-sectional study of 140,564 UK Biobank
participants,” BMC Psychiatry, vol. 14, no. 1, article no. 153, 2014.
[10] R. Sturm and K. B. Wells, “Does obesity contribute as much to
morbidity as poverty or smoking?” Public Health, vol. 115, no. 3,
pp. 229–235, 2001.
[11] C. Viola´n, Q. Foguet-Boreu, A. Roso-Llorach et al., “Burden of
multimorbidity, socioeconomic status and use of health services
across stages of life in urban areas: A Cross-Sectional Study,”
BMC Public Health, vol. 14, no. 1, article 530, 2014.
[12] C. Violan, Q. Foguet-Boreu, G. Flores-Mateo et al., “Prevalence,
determinants and patterns of multimorbidity in primary care: a
systematic review of observational studies,” PLoS ONE, vol. 9,
no. 7, Article ID e102149, 2014.
[13] A. Boutayeb, S. Boutayeb, and W. Boutayeb, “Multi-morbidity
of non communicable diseases and equity in WHO Eastern
Mediterranean countries,” International Journal for Equity in
Health, vol. 12, no. 1, article no. 60, 2013.
[14] S. Nishtar, Health Indicators of Pakistan —Gateway Paper II,
Heartfile, Pakistan, 2007.
[15] M. Abbas, P. I. Paracha, S. Khan, Z. Iqbal, and M. Iqbal, “Socio-
demographic and dietary determinants of overweight and
obesity in male pakistani adults,” European Scientific Journal,
vol. 9, no. 33, 2013.
[16] Organization World Health, “International association for the
study of obesity, international obesity task force,” in The Asia-
Pacific perspective: redefining obesity and its treatment Sydney:
Health Communications, pp. 15–21, 2000.
[17] WH. Organization,Obesity, preventing and managing the global
epidemic, World Health Organization, preventing and manag-
ing the global epidemic, 2000.
[18] G. A. Colditz, W. C. Willett, A. Rotnitzky, and J. E. Manson,
“Weight gain as a risk factor for clinical diabetes mellitus in
women,”Annals of InternalMedicine, vol. 122, no. 7, pp. 481–486,
1995.
[19] M. Grotle, K. B. Hagen, B. Natvig, F. A. Dahl, and T. K.
Kvien, “Obesity and osteoarthritis in knee, hip and/or hand: an
epidemiological study in the general population with 10 years
follow-up,” BMC Musculoskeletal Disorders, vol. 9, article 132,
2008.
[20] S. Kenchaiah, J. C. Evans, D. Levy et al., “Obesity and the risk
of heart failure,”The New England Journal of Medicine, vol. 347,
no. 5, pp. 305–313, 2002.
[21] T. Kurth, J. M. Gaziano, K. Berger et al., “Body mass index and
the risk of stroke inmen,”Archives of InternalMedicine, vol. 162,
no. 22, pp. 2557–2562, 2002.
[22] L. Niskanen, D. E. Laaksonen, K. Nyysso¨nen et al., “Inflam-
mation, abdominal obesity, and smoking as predictors of
hypertension,” Hypertension, vol. 44, no. 6, pp. 859–865, 2004.
[23] C. D. Mathers and D. Loncar, “Projections of global mortality
and burden of disease from 2002 to 2030,” PLoS Medicine, vol.
3, no. 11, article e442, 2006.
[24] A. Must, J. Spadano, E. H. Coakley, A. E. Field, G. Colditz, and
W. H. Dietz, “The disease burden associated with overweight
and obesity,” The Journal of the American Medical Association,
vol. 282, no. 16, pp. 1523–1529, 1999.
[25] A. Misra and L. Khurana, “Obesity-related non-communicable
diseases: South Asians vs White Caucasians,” International
Journal of Obesity, vol. 35, no. 2, pp. 167–187, 2011.
[26] Z. Ul-Haq, D. F. MacKay, E. Fenwick, and J. P. Pell, “Impact of
metabolic comorbidity on the association between body mass
index and health-related quality of life: A Scotland-wide cross-
sectional study of 5,608 participants,” BMC Public Health, vol.
12, no. 1, article no. 143, 2012.
BioMed Research International 9
[27] Z. Ul-Haq, D. F. MacKay, E. Fenwick, and J. P. Pell, “Association
between body mass index and mental health among Scottish
adult population: A cross-sectional study of 37272 participants,”
Psychological Medicine, vol. 44, no. 10, pp. 2231–2240, 2014.
[28] Z. Ul-Haq, D. F.Mackay, D.Martin et al., “Heaviness, health and
happiness: A cross-sectional study of 163 066 UK biobank par-
ticipants,” Journal of Epidemiology and Community Health, vol.
68, no. 4, pp. 340–348, 2014.
Submit your manuscripts at
https://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
